Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study.
Tricarico M, Nunziata C, Atzori F, Concolino F, Macchini V, D'Atri S, Prete SP, Turriziani M, Lanzilli G, Sera F, Abeni D, Albanesi V, Bonmassar E, Pagani E.
Tricarico M, et al.
J Exp Clin Cancer Res. 2004 Dec;23(4):573-8.
J Exp Clin Cancer Res. 2004.
PMID: 15743026
Clinical Trial.